Kulicke and Soffa Industries, Inc. (KLIC) Income Statement

The sequential revenue progression from $148.4M in Q3 2025 to $330.4M in Q3 2026 indicates a robust cyclical upswing, likely driven by OSAT utilization recovery and advanced packaging demand. However, the year-ago base was depressed, so investors should assess whether this growth rate is sustainable as comparisons normalize. The maintained guidance of $375M (+/-$20M) for the next quarter suggests continued acceleration, but the wide range implies uncertainty.

The gross margin recovery from the trough of 9.6% in Q2 2024 reflects better capacity utilization and product mix, but the 47.8% level is still below the 52.4% achieved in Q1 2025, suggesting that pricing power may be constrained in a competitive environment. The sequential decline from 49.5% in Q2 2026 to 47.8% in Q3 2026 warrants monitoring, as it could indicate mix shifts or input cost pressures. Given the high fixed-cost structure, gross margin is highly sensitive to volume, and the recent expansion may be cyclical rather than structural.

The dramatic swing in operating margin from -52.3% to 20.7% over five quarters demonstrates significant operating leverage, as revenue growth outpaced fixed cost absorption. However, the Q1 2025 operating margin of 52.2% was inflated by a one-time gain (likely from an asset sale), so the current 20.7% may be more representative of normalized profitability. SG&A and R&D expenses have remained relatively stable in absolute terms, indicating disciplined cost control, but the near-breakeven operating margin in Q4 2025 (0.5%) highlights the fragility of profitability at lower revenue levels.

The stability of R&D and SG&A costs during the downturn and recovery indicates management's commitment to maintaining technological competitiveness while controlling overhead. R&D spending of $43.9M in Q3 2026 is slightly elevated, reflecting investments in advanced packaging like TCB, which is necessary for long-term growth but pressures margins in the near term. SG&A of $45.8M is also relatively flat, suggesting that the company is not aggressively cutting costs, which may be prudent to support future growth but limits downside protection if demand stalls.

The Q2 2025 quarter was the inflection point, with revenue of $162.0M and a gross margin of only 24.9%, likely due to under-absorbed fixed costs and possibly inventory write-downs. The subsequent recovery in revenue and margins suggests that the semiconductor downcycle has ended, but the lasting impact is a more cautious cost structure and a focus on higher-margin advanced packaging. The sharp swing from a -$105.2M operating loss in Q2 2024 to a $68.3M profit in Q3 2026 demonstrates the company's high beta to the semiconductor cycle, which investors should factor into valuation.